Abstract
Abstract
Loco-regional control (LRC) is a major clinical endpoint after definitive radiochemotherapy (RCT) of head and neck cancer (HNC). Radiomics has been shown a promising biomarker in cancer research, however closer related to primary tumor control than composite endpoints. Radiomics studies often focus on the analysis of primary tumor (PT). We hypothesize that the combination of PT and lymph nodes (LN) radiomics better predicts LRC in HNC treated with RCT. Radiomics analysis was performed in CT images of 128 patients using Z-Rad implementation (training n = 77, validation n = 51). 285 features were extracted from PT and involved LN. Features were preselected with the maximum relevance minimum redundancy method and the multivariate Cox model was trained using least absolute shrinkage and selection operator. The mixed model was based on the combination of PT and LN radiomics, whereas the PT model included only the PT features. The mixed model showed significantly higher performance than the PT model (p < 0.01), c-index of 0.67 and 0.63, respectively; and better risk group stratification. The clinical nodal status was not a significant predictor in the combination with PT radiomics. This study shows that the LRC can be better predicted by expansion of radiomics analysis with LN features.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Vigneswaran, N. & Williams, M. D. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral and maxillofacial surgery clinics of North America 26, 123 (2014).
2. Marur, S. et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. The lancet oncology 11, 781–789 (2010).
3. Sturgis, E. M. & Cinciripini, P. M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus‐associated cancers? Cancer: Interdisciplinary International. Journal of the American Cancer Society 110, 1429–1435 (2007).
4. Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine 363, 24–35 (2010).
5. Lassen, P. et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiotherapy and Oncology 113, 310–316 (2014).
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献